Certified by Founder Lodge 
                                        
                                        Northpond Ventures
 
                                                 United States  -  Bethesda, Maryland 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $100,000,000
                                            26 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Northpond Ventures is a multi-billion dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has been named one of the three most ac
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Kyverna Therapeutics | 
                                                            August, 03 ,2023 | Series B | $60,000,000 | 
   CAMP4 Therapeutics | 
                                                            July, 20 ,2022 | Series B | $100,000,000 | 
   Aro Biotherapeutics | 
                                                            November, 29 ,2023 | Series B | $41,500,000 | 
   Delfi Diagnostics | 
                                                            July, 18 ,2022 | Series B | $225,000,000 | 
   Molecule | 
                                                            July, 01 ,2022 | Seed | $12,700,000 | 
   Elephas | 
                                                            January, 24 ,2024 | Series C | $55,000,000 | 
   DNAnexus | 
                                                            June, 09 ,2022 | Unknown | $100,000,000 | 
   Inflammatix, Inc. | 
                                                            September, 13 ,2024 | Series E | $57,000,000 | 
   Faro Health Inc. | 
                                                            February, 16 ,2023 | Unknown | $20,000,000 | 
   VieCure | 
                                                            October, 02 ,2024 | Unknown | $45,000,000 | 
   Triumvira Immunologics, Inc. | 
                                                            March, 17 ,2022 | Series A | $100,000,000 | 
   Selux Diagnostics, Inc | 
                                                            March, 01 ,2022 | Series C | $50,000,000 | 
   Eleanor Health | 
                                                            October, 08 ,2024 | Series D | $30,000,000 | 
   Octave (US) | 
                                                            July, 27 ,2023 | Series B | $30,000,000 | 
   EnPlusOne Biosciences | 
                                                            February, 21 ,2025 | Unknown | $10,000,000 | 
   Kyverna Therapeutics | 
                                                            August, 03 ,2023 | Series B | $60,000,000 | 
   QbDVision | 
                                                            May, 02 ,2025 | Unknown | $13,000,000 | 
   Aro Biotherapeutics | 
                                                            November, 29 ,2023 | Series B | $41,500,000 | 
   Outcomes4Me | 
                                                            May, 30 ,2025 | Unknown | $21,000,000 | 
   Elephas | 
                                                            January, 24 ,2024 | Series C | $55,000,000 | 
   Inflammatix, Inc. | 
                                                            September, 13 ,2024 | Series E | $57,000,000 | 
   VieCure | 
                                                            October, 02 ,2024 | Unknown | $45,000,000 | 
   Eleanor Health | 
                                                            October, 08 ,2024 | Series D | $30,000,000 | 
   EnPlusOne Biosciences | 
                                                            February, 21 ,2025 | Unknown | $10,000,000 | 
   QbDVision | 
                                                            May, 02 ,2025 | Unknown | $13,000,000 | 
   Outcomes4Me | 
                                                            May, 30 ,2025 | Unknown | $21,000,000 | 
                                                
  Kyverna Therapeutics
  CAMP4 Therapeutics
  Aro Biotherapeutics
  Delfi Diagnostics
  Molecule
  Elephas
  DNAnexus
  Inflammatix, Inc.
  Faro Health Inc.
  VieCure
  Triumvira Immunologics, Inc.
  Selux Diagnostics, Inc
  Eleanor Health
  Octave (US)
  EnPlusOne Biosciences
  QbDVision
  Outcomes4Me
Cherry Ventures
 
                                            
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                            
                                                                        
                                Vesence |  $9,000,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)